A phase 2 study of adjuvant carboplatin plus S-1 followed by maintenance S-1 therapy for patients with completely resected stage II/IIIA non-small cell lung cancer—Japanese Northern East Area Thoracic Surgery Study Group JNETS1302 study

BACKGROUND: The standard adjuvant chemotherapy regimen for completely resected pathological stage II/IIIA non-small cell lung cancer (NSCLC) is four courses of cisplatin plus vinorelbine. However, the continuity and toxicity of cisplatin-based regimens remain problematic. Conversely, carboplatin-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Takeo, Suzuki, Hiroyuki, Abe, Jiro, Sakurada, Akira, Endo, Chiaki, Sato, Nobuyuki, Hasumi, Tohru, Deguchi, Hiroyuki, Oura, Hiroyuki, Takahashi, Satomi, Saito, Hajime, Uramoto, Hidetaka, Sagawa, Motoyasu, Okada, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399402/
https://www.ncbi.nlm.nih.gov/pubmed/32802438
http://dx.doi.org/10.21037/jtd-20-715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399402/
https://www.ncbi.nlm.nih.gov/pubmed/32802438
http://dx.doi.org/10.21037/jtd-20-715

Ejemplares similares